Applying heart failure guidelines to adult congenital heart disease patients

References

• Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult – Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol.46(6), 1116–1143 (2005).
   Web of Science ®Google Scholar
• Swedberg K, Cleland J, Dargie H et al. Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005. Kardiol. Pol.63(5), 509–543; discussion 544–508 (2005).
   Google Scholar
• Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Rev. Esp. Cardiol.58(9), 1062–1092 (2005).
   PubMed Web of Science ®Google Scholar
• Redington AN. Determinants and assessment of pulmonary regurgitation in tetralogy of Fallot: practice and pitfalls. Cardiol. Clin.24(4), 631–639, vii (2006).
   PubMed Web of Science ®Google Scholar
• Sigurdsson A, Amtorp O, Gundersen T, Nilsson B, Remes J, Swedberg K. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group. Br. Heart J.72(5), 422–427 (1994).
   PubMedGoogle Scholar
• Wei CM, Lerman A, Rodeheffer RJ et al. Endothelin in human congestive heart failure. Circulation89(4), 1580–1586 (1994).
   PubMed Web of Science ®Google Scholar
• Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol.41(2), 233–243 (1978).
   PubMed Web of Science ®Google Scholar
• Eriksson SV, Eneroth P, Kjekshus J, Offstad J, Swedberg K. Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Clin. Cardiol.17(11), 603–606 (1994).
   Google Scholar
• Cohn JN, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med.311(13), 819–823 (1984).
   PubMed Web of Science ®Google Scholar
• Pousset F, Isnard R, Lechat P et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur. Heart J.18(2), 254–258 (1997).
   PubMed Web of Science ®Google Scholar
• Metra M, Nodari S, D’Aloia A et al. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure. Eur. Heart J.19(Suppl. B), B25–B35 (1998).
   Google Scholar
• Eichhorn EJ. Prognosis determination in heart failure. Am. J. Med.110(Suppl. 7A), 14–36S (2001).
   PubMedGoogle Scholar
• Bolger AP, Sharma R, Li W et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation106(1), 92–99 (2002).
   PubMed Web of Science ®Google Scholar
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med.316(23), 1429–1435 (1987).
   Google Scholar
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med.325(5), 293–302 (1991).
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med.327(10), 669–677 (1992).
   PubMed Web of Science ®Google Scholar
• Bristow MR. β-adrenergic receptor blockade in chronic heart failure. Circulation101(5), 558–569 (2000).
   PubMed Web of Science ®Google Scholar
• Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med.341(10), 709–717 (1999)
   PubMed Web of Science ®Google Scholar
• Pitt B, Remme W, Zannad F et al. Eplerenone, a selective aldosterone blocker in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med.348(14), 1309–1321 (2003)
   PubMed Web of Science ®Google Scholar
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet353(9146), 9–13 (1999).
   Google Scholar
• Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet353(9169), 2001–2007 (1999).
   Google Scholar
• Packer M, Coats AJ, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med.344(22), 1651–1658 (2001).
   PubMed Web of Science ®Google Scholar
• Packer M, Fowler MB, Roecker EB et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation106(17), 2194–2199 (2002).
   PubMed Web of Science ®Google Scholar
• Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet357(9266), 1385–1390 (2001).
   PubMed Web of Science ®Google Scholar
• Puley G, Siu S, Connelly M et al. Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. Am. J. Cardiol.83(7), 1080–1084 (1999).
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Happonen JM, Louhimo I. Late results of Senning operation. J. Thorac. Cardiovasc. Surg.117(3), 488–495 (1999).
   PubMedGoogle Scholar
• Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation105(10), 1189–1194 (2002).
   PubMed Web of Science ®Google Scholar
• Hurwitz RA, Caldwell RL, Girod DA, Brown J. Right ventricular systolic function in adolescents and young adults after Mustard operation for transposition of the great arteries. Am. J. Cardiol.77(4), 294–297 (1996).
   Google Scholar
• Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Tajik AJ, Danielson GK. Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. J. Am. Coll. Cardiol.40(2), 285–290 (2002).
   PubMed Web of Science ®Google Scholar
• Graham TP Jr, Bernard YD, Mellen BG et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J. Am. Coll. Cardiol.36(1), 255–261 (2000).
   PubMed Web of Science ®Google Scholar
• Dodge-Khatami A, Tulevski II, Bennink GB et al. Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing. Ann. Thorac. Surg.73(6), 1759–1764 (2002).
   Google Scholar
• Eicken A, Fratz S, Gutfried C et al. Hearts late after fontan operation have normal mass, normal volume, and reduced systolic function: a magnetic resonance imaging study. J. Am. Coll. Cardiol.42(6), 1061–1065 (2003).
   Google Scholar
• Giardini A, Lovato L, Donti A et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries. Am. J. Cardiol.98(9), 1277–1282 (2006).
   PubMed Web of Science ®Google Scholar
• Bos JM, Hagler DJ, Silvilairat S et al. Right ventricular function in asymptomatic individuals with a systemic right ventricle. J. Am. Soc. Echocardiogr.19(8), 1033–1037 (2006).
   Google Scholar
• Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation105(11), 1387–1393 (2002).
   PubMed Web of Science ®Google Scholar
• Fredriksen PM, Veldtman G, Hechter S et al. Aerobic capacity in adults with various congenital heart diseases. Am. J. Cardiol.87(3), 310–314 (2001).
   PubMed Web of Science ®Google Scholar
• Norozi K, Wessel A, Alpers V et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am. J. Cardiol.97(8), 1238–1243 (2006).
   PubMed Web of Science ®Google Scholar
• Diller GP, Dimopoulos K, Okonko D et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation112(6), 828–835 (2005).
   PubMed Web of Science ®Google Scholar
• Norozi K, Wessel A, Alpers V et al. Chronotropic incompetence in adolescents and adults with congenital heart disease after cardiac surgery. J. Card. Fail.13(4), 263–268 (2007).
   PubMed Web of Science ®Google Scholar
• Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation114(24), 2710–2738 (2006).
   PubMed Web of Science ®Google Scholar
• Roberts WC. Major anomalies of coronary arterial origin seen in adulthood. Am. Heart J.111(5), 941–963 (1986).
   PubMed Web of Science ®Google Scholar
• Gagliardi MG, Adorisio R, Crea F, Versacci P, Di Donato R, Sanders SP. Abnormal vasomotor function of the epicardial coronary arteries in children five to eight years after arterial switch operation: an angiographic and intracoronary Doppler flow wire study. J. Am. Coll. Cardiol.46(8), 1565–1572 (2005).
   Google Scholar
• Cowley CG, Orsmond GS, Feola P, McQuillan L, Shaddy RE. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation111(25), 3453–3456 (2005).
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Petrossian E, Tworetzky W, Silverman NH, Hanley FL. Issues and outcomes in the management of supravalvar aortic stenosis. Ann. Thorac. Surg.69(2), 562–567 (2000).
   PubMedGoogle Scholar
• Lewis AB, Heymann MA, Stanger P, Hoffman JI, Rudolph AM. Evaluation of subendocardial ischemia in valvar aortic stenosis in children. Circulation49(5), 978–984 (1974).
   Google Scholar
• Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur. J. Cardiovasc. Prev. Rehabil.13(4), 612–616 (2006).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello B, de Leon AC Jr et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation98(18), 1949–1984 (1998).
   PubMed Web of Science ®Google Scholar
• Lester SJ, McElhinney DB, Viloria E et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am. J. Cardiol.88(11), 1314–1316 (2001).
   PubMed Web of Science ®Google Scholar
• Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation96(5), 1507–1512 (1997).
   PubMed Web of Science ®Google Scholar
• Hechter SJ, Fredriksen PM, Liu P et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am. J. Cardiol.87(5), 660–663, A611 (2001).
   PubMed Web of Science ®Google Scholar
• Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation112(16), 2411–2416 (2005).
   PubMed Web of Science ®Google Scholar
• Derrick G, Deanfield JE. Decline in ventricular function and clinical condition after Mustard repair. Eur. Heart J.25(21), 1863–1864 (2004).
   Google Scholar
• Derrick GP, Josen M, Vogel M, Henein MY, Shinebourne EA, Redington AN. Abnormalities of right ventricular long axis function after atrial repair of transposition of the great arteries. Heart86(2), 203–206 (2001).
   Google Scholar
• Vogel M, Derrick G, White PA et al. Systemic ventricular function in patients with transposition of the great arteries after atrial repair: a tissue Doppler and conductance catheter study. J. Am. Coll. Cardiol.43(1), 100–106 (2004).
   PubMed Web of Science ®Google Scholar
• Josephson CB, Howlett JG, Jackson SD, Finley J, Kells CM. A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of β-blockade. Can. J. Cardiol.22(9), 769–772 (2006).
   PubMed Web of Science ®Google Scholar
• Giardini A, Lovato L, Donti A et al. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int. J. Cardiol. (2006).
   Google Scholar
• Doughan AR, McConnell ME, Book WM. Effect of β blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am. J. Cardiol.99(5), 704–706 (2007).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Yap SC, Roos-Hesselink JW, Hoendermis ES et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur. Heart J.28(15), 1854–1861 (2007).
   PubMed Web of Science ®Google Scholar
• Bernstein D, Naftel D, Chin C et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation114(4), 273–280 (2006).
   PubMedGoogle Scholar
• Coskun O, Coskun T, El-Arousy M et al. Heart transplantation in adults with congenital heart disease: experience with 15 patients. Asaio J.53(1), 103–106 (2007).
   PubMed Web of Science ®Google Scholar